BioSpecifics Technologies Corp.
BSTC
BSTC was delisted on the 1st of December, 2020.
107 hedge funds and large institutions have $263M invested in BioSpecifics Technologies Corp. in 2018 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 31 increasing their positions, 40 reducing their positions, and 7 closing their positions.
200% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 7
15% more funds holding
Funds holding: 93 → 107 (+14)
8% more capital invested
Capital invested by funds: $244M → $263M (+$19M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
23% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 40
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$5.77M |
| 2 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$4.16M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
+$1.85M |
| 4 |
BlackRock
New York
|
+$1.6M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$1.43M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$4.05M |
| 2 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$1.7M |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$1.61M |
| 4 |
TAM
THB Asset Management
Norwalk,
Connecticut
|
-$1.19M |
| 5 |
PVI
Pura Vida Investments
New York
|
-$1.18M |
BSTC Hedge Fund Activity: Q4 2018 in Review
107 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q4 2018, worth a combined $263M — up 7.8% from $244M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new BSTC positions and 7 closed out — a net gain of 14 holders — while 31 added to existing stakes and 40 trimmed.
The largest buyer was Goldman Sachs, adding an estimated $5.77M. The largest seller was Stonepine Capital Management, cutting an estimated $4.05M.
- 107 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q4 2018, up from 93 in Q3 2018.
- Funds reported $263M of BioSpecifics Technologies Corp. stock for Q4 2018, up 7.8% quarter-over-quarter.
- 21 funds opened new BioSpecifics Technologies Corp. positions in Q4 2018 and 7 closed out, a net change of +14 holders.
- The largest BioSpecifics Technologies Corp. buyer in Q4 2018 was Goldman Sachs, an estimated $5.77M added.
- The largest BioSpecifics Technologies Corp. seller in Q4 2018 was Stonepine Capital Management, an estimated $4.05M sold.
Based on aggregated 13F filings for Q4 2018.